Table 2 Characteristics of instrumental variables for rosacea.

From: Genetic analyses reveal association between rosacea and cardiovascular diseases

 

SNP

EA

OA

Sample size

SE

β

EAF

P value

R2*

F-statistic**

Reasons for exclusion after using PhenoScanner V2

1

rs5744109

G

A

431,664

0.0478

0.2354

0.0864

8.35E-07

0.87%

3809.47

 

2

rs1093515

C

T

431,664

0.0537

 − 0.2497

0.9333

3.28E-06

0.78%

3377.05

 

3

rs183330282

T

G

431,664

0.0627

 − 0.2880

0.0667

4.35E-06

1.03%

4501.70

 

4

rs13099497

G

A

431,664

0.0296

0.1359

0.3472

4.42E-06

0.84%

3644.66

 

5

rs3101056

T

C

431,664

0.1016

0.4645

0.9717

4.88E-06

1.19%

5191.63

 

6

rs11741255

A

G

431,664

0.0302

0.1591

0.3174

1.37E-07

1.10%

4786.71

Allergic disease, asthma, inflammatory bowel disease

7

rs118056540

T

C

431,664

0.1318

 − 0.6224

0.0174

2.32E-06

1.33%

5808.84

 

8

rs34693947

A

G

431,664

0.0457

0.2221

0.0988

1.17E-06

0.88%

3824.82

 

9

rs9649741

G

A

431,664

0.0292

0.1639

0.3582

2.07E-08

1.24%

5401.48

 

10

rs77269455

A

T

431,664

0.1274

0.6740

0.0086

1.23E-07

0.78%

3374.98

 

11

rs34403729

G

A

431,664

0.0325

 − 0.1682

0.2825

2.28E-07

1.15%

5004.94

 

12

rs144869084

T

C

431,664

0.0590

0.2913

0.0522

8.08E-07

0.84%

3655.59

 

13

rs476707

C

T

431,664

0.0294

 − 0.1367

0.6218

3.26E-06

0.88%

3826.11

 

14

rs4603353

A

C

431,664

0.0460

0.2155

0.8767

2.87E-06

1.00%

4376.61

 

15

rs186294774

A

T

431,664

0.1307

 − 0.6987

0.0182

9.03E-08

1.74%

7662.92

 

16

rs7222401

A

G

431,664

0.0718

 − 0.3531

0.0518

8.68E-07

1.23%

5356.06

 

17

rs12610552

A

G

431,664

0.0522

0.2418

0.0705

3.53E-06

0.77%

3332.68

 
  1. SNP:single nucleotide polymorphisms; EA: effect allele; OA: other allele; EAF: effect allele frequency; SE, standard error.
  2. NOTE: *R2 = [2 × β2 × EAF × (1 − EAF)]/[2 × β2 × EAF × (1 − EAF) + (SE × β)2 × 2 × n × EAF × (1 − EAF)]; **F-statistic = [R2 × (n − 2)]/(1 − R2).
  3. R2, the proportion of exposed variability explained by individual genetic instrument; EAF, the effect allele frequency; β, the estimated effect of SNP; n, the sample size of the exposure of GWAS.